Bulimia



Lisdexamfetamine for Adults With Bulimia Nervosa


Condition:   Bulimia Nervosa
Intervention:   Drug: Lisdexamfetamine dimesylate
Sponsors:   Aaron Keshen;   Nova Scotia Health Authority
Not yet recruiting


GH-PP-Ghrelin Loop and Sympathicolysis in Bulimia


Conditions:   Eating Disorder;   Bulimia Nervosa
Interventions:   Drug: Acipimox;   Drug: Placebo
Sponsor:   Charles University, Czech Republic
Enrolling by invitation


Binge Eating Liraglutide Intervention


Condition:   Binge-Eating Disorder
Interventions:   Drug: Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml;   Drug: Placebo
Sponsors:   Kelly Allison;   Novo Nordisk A/S
Recruiting


Weight Loss Treatment for Veterans With Binge Eating


Condition:   Binge Eating Disorder
Interventions:   Behavioral: MOVE!;   Behavioral: MOVE!+gshCBT
Sponsor:   VA Office of Research and Development
Not yet recruiting


A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder


Condition:   Binge Eating Disorder
Interventions:   Drug: dasotraline 4mg;   Drug: dasotraline 6mg;   Drug: Placebo
Sponsor:   Sunovion
Recruiting


Light Therapy and Binge Eating Disorder Treatment (BED Light Study)


Condition:   Binge-Eating Disorder
Interventions:   Device: High intensity bright light therapy;   Device: Low intensity light therapy
Sponsor:   Hospices Civils de Lyon
Not yet recruiting


Evaluating and Implementing a Smartphone Application Treatment Program for Bulimia Nervosa and Binge Eating Disorder


Conditions:   Eating Disorder;   Bulimia Nervosa;   Binge Eating Disorder
Interventions:   Behavioral: Adaptive Recovery Record App;   Behavioral: Standardized Coaching
Sponsor:   Nova Scotia Health Authority
Not yet recruiting


Dialectical Behavior Therapy Guided Self-Help for Binge Eating Disorder


Condition:   Binge Eating Disorder
Interventions:   Behavioral: DBT Guided Self-Help;   Behavioral: DBT Unguided Self-Help;   Behavioral: Self-Esteem-Focused Unguided Self-Help
Sponsor:   Memorial University of Newfoundland
Recruiting


Improving Treatments for Bulimia Nervosa: Innovation in Psychological Interventions for Regulating Eating


Conditions:   Bulimia Nervosa;   Bulimia;   Binge Eating;   Purging (Eating Disorders);   Eating Disorder
Interventions:   Behavioral: Nutritional Counseling & Acceptance-based Therapy;   Behavioral: Cognitive Behavioral Therapy for Eating Disorders
Sponsors:   Drexel University;   National Institute of Mental Health (NIMH)
Recruiting


Dasotraline Binge Eating Disorder Extension Study


Condition:   Binge Eating Disorder
Intervention:   Drug: Dasotraline
Sponsor:   Sunovion
Enrolling by invitation


Dasotraline Binge Eating Disorder Study


Condition:   Binge Eating Disorder
Interventions:   Drug: Dasotraline;   Drug: Placebo
Sponsor:   Sunovion
Completed


Noom Monitor for Binge Eating


Condition:   Binge Eating Disorder
Intervention:   Behavioral: CBT-GSH with Noom Monitor
Sponsors:   Icahn School of Medicine at Mount Sinai;   Noom Inc.;   Kaiser Permanente
Active, not recruiting


FDA Approved Medication to Reduce Binge Eating and/or Purging


Conditions:   Binge Eating Disorder;   Bulimia Nervosa
Interventions:   Drug: Phentermine/Topiramate-First;   Drug: Placebo
Sponsor:   Stanford University
Active, not recruiting


Vortioxetine for Binge Eating Disorder


Condition:   Binge Eating Disorder
Interventions:   Drug: Vortioxetine;   Drug: Placebo
Sponsors:   University of Chicago;   Takeda
Recruiting


Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF.


Condition:   Bulimia Nervosa
Interventions:   Drug: Antidepressants;   Drug: Positron Emission Tomography (PET)
Sponsors:   Centre Hospitalier Universitaire de Saint Etienne;   Ministry of Health, France
Recruiting


Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo


Condition:   Binge Eating Disorder
Interventions:   Drug: Naltrexone and bupropion combination;   Other: Pill Placebo
Sponsor:   Yale University
Completed


Virtual Reality Based Cue-exposure Treatment for Bulimia Nervosa


Conditions:   Bulimia Nervosa;   Binge-Eating Disorder;   Binge Eating
Interventions:   Behavioral: VR based cue-exposure therapy;   Behavioral: Additional Cognitive-behavioral treatment
Sponsors:   University of Barcelona;   Hospital Universitari de Bellvitge;   Consorci Sanitari de l'Anoia;   Centro ABB;   Hospital Universitari Joan XXIII de Tarragona.;   Istituto Auxologico Italiano
Completed


Integrative Cognitive-Affective Therapy for Binge Eating Disorder


Condition:   Binge Eating Disorder
Interventions:   Behavioral: Integrative Cognitive-Affective Therapy;   Behavioral: CBT-Guided Self Help
Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   Neuropsychiatric Research Institute, Fargo, North Dakota
Active, not recruiting


A Comparison of Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Binge Eating Disorder


Condition:   Binge-Eating Disorder
Interventions:   Drug: Methylphenidate;   Behavioral: Cognitive Behavioral Therapy
Sponsors:   Centre for Addiction and Mental Health;   Ontario Mental Health Foundation
Completed


Guided Self-help for Binge Eating


Conditions:   Bulimia Nervosa;   Eating Disorder Not Otherwise Specified;   Binge Eating Disorder
Interventions:   Other: Face-to-face self-help;   Other: E-mail self-help;   Other: Waiting List
Sponsor:   Oxford Health NHS Foundation Trust
Completed


Bulimia Nervosa: A Biobehavioral Study (The Eating Disorder Study)


Condition:   Bulimia Nervosa
Intervention:  
Sponsors:   Drexel University;   Columbia University;   The Miriam Hospital
Recruiting


Influence of Appetite Related Hormones in Binge Eating Behaviour Among the Overweight and Obese


Condition:   Binge Eating Behaviour
Interventions:   Drug: Liraglutide;   Behavioral: Diet and Exercise
Sponsor:   Universiti Kebangsaan Malaysia Medical Centre
Completed


Effect of a CCK-1R Agonist on Food Intake in Humans


Condition:   Bulimia
Interventions:   Drug: GSKI181771X (CCK-1R agonist);   Behavioral: Instructions to binge eat;   Behavioral: Instructions to eat normally;   Drug: Placebo
Sponsors:   St. Luke's-Roosevelt Hospital Center;   GlaxoSmithKline
Terminated


Randomised Controlled Study on the Use of Psychoeducation for Bulimia Nervosa in Young Women


Condition:   Bulimia Nervosa
Intervention:   Behavioral: Guided Self-help for Bulimia nervosa
Sponsors:   Medical University of Vienna;   National Bank of Austria
Completed


Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa


Conditions:   Bulimia Nervosa;   Eating Disorders
Interventions:   Drug: Erythromycin;   Drug: Placebo
Sponsors:   New York State Psychiatric Institute;   National Institute of Mental Health (NIMH)
Completed

Refine Your Search Advanced Search